These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

375 related articles for article (PubMed ID: 26482878)

  • 21. Telomere elongation in induced pluripotent stem cells from dyskeratosis congenita patients.
    Agarwal S; Loh YH; McLoughlin EM; Huang J; Park IH; Miller JD; Huo H; Okuka M; Dos Reis RM; Loewer S; Ng HH; Keefe DL; Goldman FD; Klingelhutz AJ; Liu L; Daley GQ
    Nature; 2010 Mar; 464(7286):292-6. PubMed ID: 20164838
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Proliferative defects in dyskeratosis congenita skin keratinocytes are corrected by expression of the telomerase reverse transcriptase, TERT, or by activation of endogenous telomerase through expression of papillomavirus E6/E7 or the telomerase RNA component, TERC.
    Gourronc FA; Robertson mM; Herrig AK; Lansdorp PM; Goldman FD; Klingelhutz AJ
    Exp Dermatol; 2010 Mar; 19(3):279-88. PubMed ID: 19558498
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Telomere biology disorders: time for moving towards the clinic?
    Batista LFZ; Dokal I; Parker R
    Trends Mol Med; 2022 Oct; 28(10):882-891. PubMed ID: 36057525
    [TBL] [Abstract][Full Text] [Related]  

  • 24. TOE1 acts as a 3' exonuclease for telomerase RNA and regulates telomere maintenance.
    Deng T; Huang Y; Weng K; Lin S; Li Y; Shi G; Chen Y; Huang J; Liu D; Ma W; Songyang Z
    Nucleic Acids Res; 2019 Jan; 47(1):391-405. PubMed ID: 30371886
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dyskeratosis congenita: the diverse clinical presentation of mutations in the telomerase complex.
    Vulliamy TJ; Dokal I
    Biochimie; 2008 Jan; 90(1):122-30. PubMed ID: 17825470
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Domain specific mutations in dyskerin disrupt 3' end processing of scaRNA13.
    Nagpal N; Tai AK; Nandakumar J; Agarwal S
    Nucleic Acids Res; 2022 Sep; 50(16):9413-9425. PubMed ID: 36018809
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Telomere-related lung fibrosis is diagnostically heterogeneous but uniformly progressive.
    Newton CA; Batra K; Torrealba J; Kozlitina J; Glazer CS; Aravena C; Meyer K; Raghu G; Collard HR; Garcia CK
    Eur Respir J; 2016 Dec; 48(6):1710-1720. PubMed ID: 27540018
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dyskeratosis congenita: telomerase, telomeres and anticipation.
    Marrone A; Walne A; Dokal I
    Curr Opin Genet Dev; 2005 Jun; 15(3):249-57. PubMed ID: 15917199
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical mutations in the TERT and TERC genes coding for telomerase components induced oxidative stress, DNA damage at telomeres and cell apoptosis besides decreased telomerase activity.
    Fernández-Varas B; Manguan-García C; Rodriguez-Centeno J; Mendoza-Lupiáñez L; Calatayud J; Perona R; Martín-Martínez M; Gutierrez-Rodriguez M; Benítez-Buelga C; Sastre L
    Hum Mol Genet; 2024 Apr; 33(9):818-834. PubMed ID: 38641551
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparable Effects of the Androgen Derivatives Danazol, Oxymetholone and Nandrolone on Telomerase Activity in Human Primary Hematopoietic Cells from Patients with Dyskeratosis Congenita.
    Vieri M; Kirschner M; Tometten M; Abels A; Rolles B; Isfort S; Panse J; Brümmendorf TH; Beier F
    Int J Mol Sci; 2020 Sep; 21(19):. PubMed ID: 33003434
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibition of telomerase RNA decay rescues telomerase deficiency caused by dyskerin or PARN defects.
    Shukla S; Schmidt JC; Goldfarb KC; Cech TR; Parker R
    Nat Struct Mol Biol; 2016 Apr; 23(4):286-92. PubMed ID: 26950371
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification and functional characterization of 2 variant alleles of the telomerase RNA template gene (TERC) in a patient with dyskeratosis congenita.
    Ly H; Schertzer M; Jastaniah W; Davis J; Yong SL; Ouyang Q; Blackburn EH; Parslow TG; Lansdorp PM
    Blood; 2005 Aug; 106(4):1246-52. PubMed ID: 15886322
    [TBL] [Abstract][Full Text] [Related]  

  • 33. mRNA deadenylation and telomere disease.
    Mason PJ; Bessler M
    J Clin Invest; 2015 May; 125(5):1796-8. PubMed ID: 25893598
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Genetic heterogeneity in autosomal recessive dyskeratosis congenita with one subtype due to mutations in the telomerase-associated protein NOP10.
    Walne AJ; Vulliamy T; Marrone A; Beswick R; Kirwan M; Masunari Y; Al-Qurashi FH; Aljurf M; Dokal I
    Hum Mol Genet; 2007 Jul; 16(13):1619-29. PubMed ID: 17507419
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Telomere dynamics and hematopoietic differentiation of human DKC1-mutant induced pluripotent stem cells.
    Donaires FS; Alves-Paiva RM; Gutierrez-Rodrigues F; da Silva FB; Tellechea MF; Moreira LF; Santana BA; Traina F; Dunbar CE; Winkler T; Calado RT
    Stem Cell Res; 2019 Oct; 40():101540. PubMed ID: 31479877
    [TBL] [Abstract][Full Text] [Related]  

  • 36. HuR regulates telomerase activity through TERC methylation.
    Tang H; Wang H; Cheng X; Fan X; Yang F; Zhang M; Chen Y; Tian Y; Liu C; Shao D; Jiang B; Dou Y; Cong Y; Xing J; Zhang X; Yi X; Songyang Z; Ma W; Zhao Y; Wang X; Ma J; Gorospe M; Ju Z; Wang W
    Nat Commun; 2018 Jun; 9(1):2213. PubMed ID: 29880812
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The PARN, TOE1, and USB1 RNA deadenylases and their roles in non-coding RNA regulation.
    Huynh TN; Parker R
    J Biol Chem; 2023 Sep; 299(9):105139. PubMed ID: 37544646
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Human telomere disease due to disruption of the CCAAT box of the TERC promoter.
    Aalbers AM; Kajigaya S; van den Heuvel-Eibrink MM; van der Velden VH; Calado RT; Young NS
    Blood; 2012 Mar; 119(13):3060-3. PubMed ID: 22323451
    [TBL] [Abstract][Full Text] [Related]  

  • 39. TERC and TERT gene mutations in patients with bone marrow failure and the significance of telomere length measurements.
    Du HY; Pumbo E; Ivanovich J; An P; Maziarz RT; Reiss UM; Chirnomas D; Shimamura A; Vlachos A; Lipton JM; Goyal RK; Goldman F; Wilson DB; Mason PJ; Bessler M
    Blood; 2009 Jan; 113(2):309-16. PubMed ID: 18931339
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impaired Telomere Maintenance and Decreased Canonical WNT Signaling but Normal Ribosome Biogenesis in Induced Pluripotent Stem Cells from X-Linked Dyskeratosis Congenita Patients.
    Gu BW; Apicella M; Mills J; Fan JM; Reeves DA; French D; Podsakoff GM; Bessler M; Mason PJ
    PLoS One; 2015; 10(5):e0127414. PubMed ID: 25992652
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.